Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EP300 mutation
i
Other names:
EP300, E1A binding protein p300, p300, KAT3B, RSTS2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2033
Related biomarkers:
Expression
Mutation
Others
‹
›
Associations
(2)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Study to Evaluate CCS1477 in Advanced Tumours (NCT03568656)
Phase 1/2
CellCentric Ltd.
CellCentric Ltd.
Recruiting
Phase 1/2
CellCentric Ltd.
Recruiting
Last update posted :
01/19/2024
Initiation :
07/23/2018
Primary completion :
03/01/2024
Completion :
03/01/2024
MYC • AR • ARID1A • CREBBP
|
ARID1A mutation • CREBBP mutation • EP300 mutation
|
Lynparza (olaparib) • Tecentriq (atezolizumab) • enzalutamide • abiraterone acetate • Nubeqa (darolutamide) • inobrodib (CCS1477)
Share
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.